$1.600
+0.235 (+14.70%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NRSN Prediction & Forecast by Similar Chart Analysis
Alphio's NRSN stock price prediction model matches the current Neurosense Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.58 (-1.38%). The 1-week path is $1.59 (-0.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Neurosense Therapeutics Ltd Stock?
Neurosense Therapeutics Ltd is currently not a good buy due to significant financial losses and a delayed Phase 3 study. The current price is $1.60, which is far below the analyst target of $3.50 from Roth Capital, indicating potential upside but also high risk. The company's RSI is at 38.737, suggesting it is nearing oversold territory, but the overall trend remains negative with a 5-day change of -19.60%.
NRSN stock price ended at $1.60 on Friday, after rising +14.70%
Neurosense Therapeutics Ltd (NRSN) last closed at $1.6, gaining +14.70%. These facts feed the 1-day and 1-week NRSN price prediction above.
Forecast Drivers
Neurosense Therapeutics Ltd (NRSN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NRSN, ranked by similarity.
Seasonality analysis for NRSN
Historically the probability of a positive November return for NRSN is 52.27%. May offers the highest probability of a positive month at 82.54%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NRSN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.69 | $1.82 | $1.94 | +13.79% |
| Dec 2026 | $2.00 | $2.21 | $2.41 | +38.25% |
In 2026, Neurosense Therapeutics Ltd (NRSN) is projected to range from $1.69 to $2.41.
Neurosense Therapeutics Ltd 2026 monthly forecast
In Nov 2026, Neurosense Therapeutics Ltd is projected to average $1.82, with a low of $1.69 and high of $1.94.
In Dec 2026, Neurosense Therapeutics Ltd is projected to average $2.21, with a low of $2.00 and high of $2.41.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.